Regression of focal nodular hyperplasia of the liver after oral contraceptive discontinuation.
There is uncertainty regarding the role, if any, of oral contraceptive steroids in the development of focal nodular hyperplasia of the liver. A case of focal nodular hyperplasia of the liver diagnosed by scintigraphy in a 33-year-old woman is presented. The lesion regressed in a dramatic way after oral contraceptive discontinuation. This case report suggests that oral contraceptives may influence the natural history of focal nodular hyperplasia of the liver, and that a trophic effect on the liver lesion is quite possible.
Côté
C
C
Department of Nuclear Medicine, C. H. Beauce-Etchemin, Beauceville, Quebec, Canada.
D000328:Adult; D003276:Contraceptives, Oral / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006965:Hyperplasia; D008099:Liver / Q000098:blood supply / Q000000981:diagnostic imaging / Q000187:drug effects / Q000473:pathology*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013667:Technetium
D003276:Contraceptives, Oral; D019275:Radiopharmaceuticals; D013667:Technetium